Ovid Therapeutics (OVID)

Ovid Therapeutics (OVID) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• OVID last traded at $2.58, -5.84% on the day.
• Ovid Therapeutics: market cap $535.12M, P/E -5.4, revenue $7.86M over the last four quarters, next earnings 2026-11-11.
• Over the past year OVID returned 93.98%; year to date 58.28%.

Updated 2026-11-06 11:46 UTC